We are maintaining a list of research on the potential for IV Vitamin C therapy to be a supportive treatment for COVID-19 patients.

Video Update from Dr Cheng in China about the use of Vitamin C for Covid-19

We agree with Dr Cheng that it's great to hear that a NY hospital chain began to recommend high-dose IVC for Covid-19 treatment. But their doses are too small and may not achieve the optimal results that high-dose IVC can offer.

We greatly appreciate Dr. Paul Anderson joining the movement to recommend fast track adoption of IV Vitamin C for COVID-19 Patients.

Our recruitment in the GMA San Rafael office and the OMASD San Diego office will continue into 2020. The process is simple, and the Biobank is already providing samples to researchers that may give us the answers we need. Get Pre-Screened and start the New Year right!

Bay Area Lyme Foundation has now funded more than 100 research projects at 38 institutions around the country since its inception in 2012. BALF is the parent of the Lyme Disease Biobank, which has now provided samples to more than 45 research projects.

All four Gordon Medical practitioners plan to attend the upcoming ILADS conference in Boston.  Our PA, Carolyn Welcome, has a special reason to be present this year, when the Pioneer in Lyme Award dinner on November 1, 2019 will honor the lifetime achievement of Bernard D. Raxlen, MD, a founding member and past Board member of ILADS. 

In a study designed to test the utility of targeted metabolomics in the diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), researchers identified a unique chemical signature that differentiates affected patients from healthy individuals….

Gordon is a co-author of the study, and most of the patients in the study came from his practice.

Their study, “Metabolic features of chronic fatigue syndrome” — published in the latest issue of the Proceedings of the National Academy of Sciences — said the discovery “opens a fresh path for the rational development of new therapeutics” for a condition that currently has no known cause, cure or even an established diagnosis.

Chronic fatigue syndrome is a multisystem disease that causes long-term pain and disability. It is difficult to diagnose because of its protean symptoms and the lack of a diagnostic laboratory test. We report that targeted, broad-spectrum metabolomics of plasma not only revealed a characteristic chemical signature but also revealed an unexpected underlying biology….